Repligen Corp (RGEN) Misses Q4 EPS by 3c, Raises FY12 Revenue Guidance
Tweet Send to a Friend
Repligen Corp (NASDAQ: RGEN) reported Q4 EPS of ($0.06), $0.03 worse than the analyst estimate ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
